Strategies towards expansion of chemical space of natural product-based compounds to enable drug discovery

被引:7
|
作者
Silva, Daniel Gedder [1 ]
Emery, Flavio da Silva [1 ]
机构
[1] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Pharmaceut Sci, Ribeirao Preto, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
Chemical space; Natural products; Ring distortion; Fragment-based drug discovery; Diversity-oriented synthesis; Chemical degradation; BIOLOGY-ORIENTED SYNTHESIS; CELL-MIGRATION INHIBITORS; RING-DISTORTION STRATEGY; STRUCTURALLY DIVERSE; ORGANIC-CHEMISTRY; FRAGMENT LIBRARY; COMPLEX; COLLECTION; DESIGN; MOLECULES;
D O I
10.1590/s2175-97902018000001004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Natural products (NPs) are an excellent source of biologically active molecules that provide many biologically biased features that enable innovative designing of synthetic compounds. NPs are characterized by high content of sp3-hybridized carbon atoms; oxygen; spiro, bridged, and linked systems; and stereogenic centers, with high structural diversity. To date, several approaches have been implemented for mapping and navigating into the chemical space of NPs to explore the different aspects of chemical space. The approaches providing novel opportunities to synthesize NP-inspired compound libraries involve NP-based fragments and ring distortion strategies. These methodologies allow access to areas of chemical space that are less explored, and consequently help to overcome the limitations in the use of NPs in drug discovery, such as lack of accessibility and synthetic intractability. In this review, we describe how NPs have recently been used as a platform for the development of diverse compounds with high structural and stereochemical complexity. In addition, we show developed strategies aiming to reengineer NPs toward the expansion of NP-based chemical space by fragment-based approaches and chemical degradation to yield novel compounds to enable drug discovery.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Natural Product-Based Drug Discovery
    Li, Rongshi
    MEDICINAL RESEARCH REVIEWS, 2016, 36 (01) : 3 - 3
  • [2] Cheminformatics in Natural Product-Based Drug Discovery
    Chen, Ya
    Kirchmair, Johannes
    MOLECULAR INFORMATICS, 2020, 39 (12)
  • [3] Introduction: Natural product-based drug discovery in Immunopharmacology
    Abe, Fuminori
    Marceau, Francois
    Talmadge, James E.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 37 : 1 - 2
  • [4] Tools for drug discovery: Natural product-based libraries
    Grabley, S
    Thiericke, R
    Sattler, I
    ROLE OF NATURAL PRODUCTS IN DRUG DISCOVERY, 2000, 32 : 217 - 252
  • [5] Keynote Lecture "Cheminformatics in natural product-based drug discovery"
    Chen, Y.
    Kirchmair, J.
    PLANTA MEDICA, 2022, 88 (15) : 1401 - 1401
  • [6] Recent developments in natural product-based drug discovery for tuberculosis
    Dong, Maryline
    Pfeiffer, Bernhard
    Altmann, Karl-Heinz
    DRUG DISCOVERY TODAY, 2017, 22 (03) : 585 - 591
  • [7] A case history in natural product-based drug discovery: discovery of vorapaxar (Zontivity™)
    Chackalamannil, Samuel
    MEDICINAL CHEMISTRY RESEARCH, 2022, 31 (10) : 1623 - 1636
  • [8] A case history in natural product-based drug discovery: discovery of vorapaxar (Zontivity™)
    Samuel Chackalamannil
    Medicinal Chemistry Research, 2022, 31 : 1623 - 1636
  • [9] Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?
    Bisson, Jonathan
    McAlpine, James B.
    Friesen, J. Brent
    Chen, Shao-Nong
    Graham, James
    Pauli, Guido F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) : 1671 - 1690
  • [10] Endophytes: exploiting biodiversity for the improvement of natural product-based drug discovery
    Staniek, Agata
    Woerdenbag, Herman J.
    Kayser, Oliver
    JOURNAL OF PLANT INTERACTIONS, 2008, 3 (02) : 75 - 93